92 related articles for article (PubMed ID: 32293976)
1. Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma.
Kajiyama H; Suzuki S; Shimbo A; Utsumi F; Yoshikawa N; Kikkawa F
J Palliat Med; 2020 Aug; 23(8):1060-1065. PubMed ID: 32293976
[No Abstract] [Full Text] [Related]
2. Is there any association between where patients spend the end of life and survival after anticancer treatment for gynecologic malignancy?
Kajiyama H; Utsumi F; Higashi M; Sakata J; Sekiya R; Mizuno M; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Niimi K; Shibata K; Kikkawa F
J Palliat Med; 2014 Mar; 17(3):325-30. PubMed ID: 24617316
[TBL] [Abstract][Full Text] [Related]
3. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study.
Harano K; Yonemori K; Hirakawa A; Shimizu C; Katsumata N; Gemma A; Fujiwara Y; Tamura K
Breast Cancer; 2016 Sep; 23(5):797-806. PubMed ID: 26439379
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
Matsuo K; Huang Y; Zivanovic O; Shimada M; Machida H; Grubbs BH; Roman LD; Wright JD
Gynecol Oncol; 2019 Sep; 154(3):505-515. PubMed ID: 31279493
[TBL] [Abstract][Full Text] [Related]
5. Determinants of death in an inpatient hospice for terminally ill cancer patients.
Tang ST; McCorkle R; Bradley EH
Palliat Support Care; 2004 Dec; 2(4):361-70. PubMed ID: 16594398
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
[TBL] [Abstract][Full Text] [Related]
7. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
8. Inverse Association between Platelet-Lymphocyte Ratio and Prognosis in Terminally Ill Cancer Patients: A Preliminary Study.
Lee Y; Kim YW; Park DK; Hwang IC
J Palliat Med; 2017 May; 20(5):533-537. PubMed ID: 27858496
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer.
Utsumi F; Kajiyama H; Niimi K; Sekiya R; Sakata J; Suzuki S; Shibata K; Mizuno M; Kikkawa F
J Obstet Gynaecol Res; 2017 Feb; 43(2):365-370. PubMed ID: 28150408
[TBL] [Abstract][Full Text] [Related]
10. Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study.
Huang WW; Hsieh KP; Huang RY; Yang YH
Kaohsiung J Med Sci; 2017 Jun; 33(6):308-314. PubMed ID: 28601236
[TBL] [Abstract][Full Text] [Related]
11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.
Klatte T; Fife K; Welsh SJ; Sachdeva M; Armitage JN; 'Aho T; Riddick AC; Matakidou A; Eisen T; Stewart GD
World J Urol; 2018 Mar; 36(3):417-425. PubMed ID: 29256020
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.
Lee TS; Lee JY; Kim JW; Oh S; Seong SJ; Lee JM; Kim TJ; Cho CH; Kim SM; Park CY
Gynecol Oncol; 2013 Nov; 131(2):289-93. PubMed ID: 23994534
[TBL] [Abstract][Full Text] [Related]
14. Accurate Prognostic Awareness Facilitates, Whereas Better Quality of Life and More Anxiety Symptoms Hinder End-of-Life Care Discussions: A Longitudinal Survey Study in Terminally Ill Cancer Patients' Last Six Months of Life.
Tang ST; Chen CH; Wen FH; Chen JS; Chang WC; Hsieh CH; Chou WC; Hou MM
J Pain Symptom Manage; 2018 Apr; 55(4):1068-1076. PubMed ID: 29289656
[TBL] [Abstract][Full Text] [Related]
15. Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.
Gonsalves WI; Tashi T; Krishnamurthy J; Davies T; Ortman S; Thota R; Aldoss I; Ganta A; Kalaiah M; Didwaniya N; Eberle C; Ganti AK; Silberstein PT; Subbiah S
J Palliat Med; 2011 Nov; 14(11):1231-5. PubMed ID: 21877925
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic nomogram for terminally ill cancer patients.
Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
[TBL] [Abstract][Full Text] [Related]
17. Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Montanari E; Acquati P; Briganti A; Carmignani L; Karakiewicz PI
Clin Genitourin Cancer; 2019 Feb; 17(1):e97-e103. PubMed ID: 30337106
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.
Liu Z; Huang J; Li X; Huang C; Ye Y; Zhang J; Liu Z
Cancer Med; 2020 Aug; 9(16):5756-5766. PubMed ID: 32585775
[TBL] [Abstract][Full Text] [Related]
19. Impact of high self-perceived burden to others with preferences for end-of-life care and its determinants for terminally ill cancer patients: a prospective cohort study.
Tang ST; Hsieh CH; Chiang MC; Chen JS; Chang WC; Chou WC; Hou MM
Psychooncology; 2017 Jan; 26(1):102-108. PubMed ID: 26950036
[TBL] [Abstract][Full Text] [Related]
20. Nutritional predictors of survival in terminally ill cancer patients.
Ho SY; Guo HR; Chen HH; Peng CJ
J Formos Med Assoc; 2003 Aug; 102(8):544-50. PubMed ID: 14569319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
